Answers are grounded in this paper and cite their sources.
Introduction: Alopecia is a benign hair condition that causes reduced hair growth on the scalp and has afflicted populations worldwide. Aim: The present study is designed to formulate and characterize submicron emulsion-based topical gel containing an anti-hypertensive drug like minoxidil to overcome the adverse effects of conventional oral dosage forms & to provide an improved, targetted therapy for the treatment of alopecia. Methods: The minoxidil-loaded submicron emulsion was prepared by aqueous titration method using a suitable combination of Clove oil (oil phase), Tween 20 (surfactant), and Transcutol P (co-surfactant). Results: The maximum submicron emulsion area obtained after constructing pseudo-ternary phase diagrams was found in S\(ₘᵢₓ\) ratio 4:1. The optimized submicron emulsion formulation (M5) exhibited a pH of 5.4 \(±\) 0.17, in vitro release of 95.08 \(±\) 0.36%, ex vivo permeation of 79.36 \(±\) 0.18%, the particle size of 181.3nm with an uniform particle size distribution \((<1)\) and optimum zeta potential (-8.80 mV). The optimized formulation (M5) was then converted to intogel formulation by adding different concentrations (1%, 1.5%, and 2% w/v) of gelling agents like Carbopol 934. Among them, M5\(2 w/v\) was considered to be the optimized gel formulation based on different evaluation studies. The optimized submicron emulsion-based gel formulation also showed an inherited anti-oxidant potential and remained stable for three months at \(4∘\). Conclusion: The minoxidil-loaded submicron emulsion-based topical gel formulation could be considered a beneficial nano-approach in contrast to other traditional topical dosage forms for treating alopecia.
No takes yet. Share an insight, caveat, or question.
Narang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: